Scaling up access to high-quality harm reduction, treatment and care for injecting drug users

During December 2009 – June 2012, the WHO/Europe HIV/AIDS, STIs and Viral hepatitis (HSV) programme carried out several activities to scale up access to high quality harm reduction, treatment and care for injecting drug users (IDUs) in the WHO European Region. The activities were carried out as part of a grant agreement between WHO/Europe and the Executive Agency for Health and Consumers (EAHC), acting under powers delegated by the European Commission (EC). The London School for Hygiene and Tropical Medicine (LSHTM) and the Eurasian Harm Reduction Network (EHRN) were key collaborating partners within the project.